Literature DB >> 25846093

Radiotherapy dose and fractionation for stage III NSCLC.

José Belderbos1, Iris Walraven2, Judi van Diessen2, Marcel Verheij2, Dirk de Ruysscher3.   

Abstract

Mesh：

Year:  2015        PMID： 25846093     DOI： 10.1016/S1470-2045(15)70121-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.

Authors:  Shijie Shang; Ruiyang Wang; Fei Wang; Meng Wu; Dawei Chen; Jinming Yu
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

2.  Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.

Authors:  Joe Y Chang; Vivek Verma; Ming Li; Wencheng Zhang; Ritsuko Komaki; Charles Lu; Pamela K Allen; Zhongxing Liao; James Welsh; Steven H Lin; Daniel Gomez; Melenda Jeter; Michael O'Reilly; Ronald X Zhu; Xiaodong Zhang; Heng Li; Radhe Mohan; John V Heymach; Ara A Vaporciyan; Stephen Hahn; James D Cox
Journal:  JAMA Oncol       Date:  2017-08-10       Impact factor: 31.777

3.  Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

Authors:  Johanna Ramroth; David J Cutter; Sarah C Darby; Geoff S Higgins; Paul McGale; Mike Partridge; Carolyn W Taylor
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-25       Impact factor: 7.038

Review 4.  A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer.

Authors:  Li Ma; Yu Men; Lingling Feng; Jingjing Kang; Xin Sun; Meng Yuan; Wei Jiang; Zhouguang Hui
Journal:  Radiol Oncol       Date:  2019-03-03       Impact factor: 2.991

5.  Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring 18F-FDG-PET/CT.

Authors:  Tineke W H Meijer; Robin Wijsman; Edwin A Usmanij; Olga C J Schuurbiers; Peter van Kollenburg; Liza Bouwmans; Johan Bussink; Lioe-Fee de Geus-Oei
Journal:  Phys Imaging Radiat Oncol       Date:  2018-08-31

Review 6.  High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.

Authors:  Brane Grambozov; Markus Stana; Bernhard Kaiser; Josef Karner; Sabine Gerum; Elvis Ruznic; Barbara Zellinger; Raphaela Moosbrugger; Michael Studnicka; Gerd Fastner; Felix Sedlmayer; Franz Zehentmayr
Journal:  Cancers (Basel)       Date:  2022-01-23       Impact factor: 6.639

7.  Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer.

Authors:  Junjie Miao; Hui Yan; Yuan Tian; Pan Ma; Zhiqiang Liu; Minghui Li; Wenting Ren; Jiayun Chen; Ye Zhang; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2017-10-11       Impact factor: 2.102
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.